---
layout: entry
title: "[The risk of acquired long QT syndrome during a coronavirus epidemic. Focus on hydroxychloroquine]"
link: "https://doi.org/10.1556/650.2020.31817"
author:
- Tomcsanyi, Janos; Tomcsanyi, Kristof

summary:
- "Hydroxychloroquine is an immunomodulatory agent used primarily in malaria, lupus erythematosus, and rheumatoid arthritis. The topicality of the present summary is given by the more frequent use of hydroxychloroquin (currently without evidence) in the COVID-19 epidemic. Orv Hetil. 2020; 161 (171): 689-691."

original:
- "Hydroxychloroquine is an immunomodulatory agent used primarily in malaria, lupus erythematosus, and rheumatoid arthritis. The authors summarize the potential proarrhythmic effect of this formulation and the key signs of drug-induced long QT syndrome. The topicality of the present summary is given by the more frequent use of hydroxychloroquine (currently without evidence) in the COVID-19 epidemic. Orv Hetil. 2020; 161 (17): 689-691."
---

